Consistent with our results regarding EMT, a pulmonary fibrosis study showed that treatment of MRC-5 and A549 cells with AXT led to upregulation of E-cadherin and downregulation of vimentin in vitro [27]. The gene discussed is VIM; the disease is pulmonary fibrosis.